92 Safety & Efficacy of Adipose-derived Stem Cells in Acute Burns: A Randomized Placebo-Controlled Phase-I Trial(ASCAB)

MLA

Rangatchew, Filip, et al. “92 Safety & Efficacy of Adipose-Derived Stem Cells in Acute Burns: A Randomized Placebo-Controlled Phase-I Trial(ASCAB).” Journal of Burn Care & Research, vol. 45, no. 1, Number 1 Supplement 1, May 2024, pp. 74–75. EBSCOhost, https://doi.org/10.1093/jbcr/irae036.091.

APA

Rangatchew, F., Melchior, L., Talman, M.-L., Litman, T., Kastrup, J., Drzewiecki, K., & Holmgaard, R. (2024). 92 Safety & Efficacy of Adipose-derived Stem Cells in Acute Burns: A Randomized Placebo-Controlled Phase-I Trial(ASCAB). Journal of Burn Care & Research, 45(1, Number 1 Supplement 1), 74–75. https://doi.org/10.1093/jbcr/irae036.091

Chicago

Rangatchew, Filip, Linea Melchior, Maj-Lis Talman, Thomas Litman, Jens Kastrup, Krzysztof Drzewiecki, and Rikke Holmgaard. 2024. “92 Safety & Efficacy of Adipose-Derived Stem Cells in Acute Burns: A Randomized Placebo-Controlled Phase-I Trial(ASCAB).” Journal of Burn Care & Research 45 (1, Number 1 Supplement 1): 74–75. doi:10.1093/jbcr/irae036.091.